rs745881769
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_173551.5(ANKS6):c.193G>T(p.Val65Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00286 in 1,264,420 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_173551.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKS6 | NM_173551.5 | c.193G>T | p.Val65Phe | missense_variant | 1/15 | ENST00000353234.5 | NP_775822.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKS6 | ENST00000353234.5 | c.193G>T | p.Val65Phe | missense_variant | 1/15 | 1 | NM_173551.5 | ENSP00000297837.6 | ||
ANKS6 | ENST00000375019.6 | c.-42+385G>T | intron_variant | 5 | ENSP00000364159.2 | |||||
ANKS6 | ENST00000471846.1 | n.241G>T | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00198 AC: 298AN: 150438Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00377 AC: 48AN: 12730Hom.: 1 AF XY: 0.00408 AC XY: 31AN XY: 7598
GnomAD4 exome AF: 0.00297 AC: 3312AN: 1113874Hom.: 10 Cov.: 30 AF XY: 0.00293 AC XY: 1562AN XY: 533436
GnomAD4 genome AF: 0.00198 AC: 298AN: 150546Hom.: 0 Cov.: 33 AF XY: 0.00188 AC XY: 138AN XY: 73456
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | The c.193G>T (p.V65F) alteration is located in exon 1 (coding exon 1) of the ANKS6 gene. This alteration results from a G to T substitution at nucleotide position 193, causing the valine (V) at amino acid position 65 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Nephronophthisis 16 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2023 | - - |
ANKS6-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 19, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at